{"id":502,"date":"2023-09-21T20:52:20","date_gmt":"2023-09-21T20:52:20","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?page_id=502"},"modified":"2023-09-21T20:52:20","modified_gmt":"2023-09-21T20:52:20","slug":"terms-of-use","status":"publish","type":"page","link":"https:\/\/vigilantbiosciences.com\/tr\/kullanim-sartlari\/","title":{"rendered":"Kullan\u0131m Ko\u015fullar\u0131"},"content":{"rendered":"

[et_pb_section fb_built=\u201d1\u2033custom_padding_last_edited=\u201don|phone\u201d _builder_version=\u201d4.22.1\u2033 _dynamic_attributes=\u201dbackground_image\u201d _module_preset=\u201ddefault\u201d use_background_color_gradient=\u201don\u201dbackground_color_gradient_stops=\u201drgba(0,142,168,0,5) 0%|rgba(0,142,168 ,0,5) 100%\u201d arka plan_color_gradient_overlays_image=\u201don\u201d arka plan_image=\u201d@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9mZWF0dXJlZF9pbWFnZSIsInNldHRpbmdzIjp7fX0=@\u201d \u00f6zel_ padding=\u201d100px||100px||true|false\u201dcustom_padding_tablet=\u201d80px||80px||true|false\u201dcustom_padding_phone= \u201d50px||50px||true|false\u201d daralt\u0131lm\u0131\u015f=\u201don\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.20.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d4_4 \u2033 _builder_version=\u201d4.20.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][et_pb_text _builder_version=\u201d4.22.1\u2033 _module_preset=\u201ddefault\u201d head_font=\u201d|600|||||||\u201d head_letter_spacing=\u201d-3px\u201d text_orientation=\u201dcenter\u201d arka plan_layout=\u201ddark\u201d hover_enabled=\u201d0\u2033 global_colors_info=\u201d{}\u201d sticky_enabled=\u201d0\u2033]<\/p>\n

Kullan\u0131m Ko\u015fullar\u0131<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u201d1\u2033custom_padding_last_edited=\u201don|tablet\u201d _builder_version=\u201d4.20.0\u2033 _module_preset=\u201ddefault\u201dcustom_margin=\u201d||0px|| false|false\u201d Custom_padding=\u201d80px||20px||false|false\u201d Custom_padding_tablet=\u201d50px||50px||true|false\u201d Custom_padding_phone=\u201d50px||50px||true|false\u201d lock=\u201doff\u201d daralt\u0131lm\u0131\u015f= \u201don\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.20.0\u2033 _module_preset=\u201ddefault\u201d width=\u201d90%\u201dcustom_padding=\u201d||50px||false|false\u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.20.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][et_pb_text _builder_version=\u201d4.22.1\u2033 _module_preset=\u201ddefault\u201dheader_2_text_align=\u201dcenter\u201dheader_3_text_align=\u201dcenter\u201d hover_enabled= \u201d0\u2033 global_colors_info=\u201d{}\u201d sticky_enabled=\u201d0\u2033]<\/p>\n

\u00a0<\/span>https:\/\/vigilantbiosciences.com'a ho\u015f geldiniz <\/a>, Vigilant Biosciences\u00ae, Inc.'in web sitesi (\"Vigilant\", \"biz\" veya \"bize\"). Vigilant Web Sitesi (\u201cWeb Sitesi\u201d) Vigilant ve \u00fcr\u00fcnleri hakk\u0131nda genel bilgi sa\u011flamak \u00fczere tasarlanm\u0131\u015ft\u0131r ve Vigilant bu Web Sitesini \u0130nternet toplulu\u011funa bir hizmet olarak s\u00fcrd\u00fcrmektedir. Bu Web Sitesinde yer alan bilgiler yat\u0131r\u0131m veya t\u0131bbi tavsiye sa\u011flama amac\u0131 ta\u015f\u0131mamaktad\u0131r. Her ne kadar bunu yapma zorunlulu\u011fu olmasa da, Vigilant bu Kullan\u0131m Ko\u015fullar\u0131n\u0131 zaman zaman bildirimde bulunmaks\u0131z\u0131n bu g\u00f6nderiyi g\u00fcncelleyerek de\u011fi\u015ftirebilir, bu nedenle l\u00fctfen g\u00fcncellemeler i\u00e7in d\u00fczenli olarak tekrar kontrol edin. Bu Web Sitesine eri\u015ferek ve kullanarak, g\u00fcncellenmi\u015f Kullan\u0131m Ko\u015fullar\u0131na ba\u011fl\u0131 kalmay\u0131 kabul etmi\u015f olursunuz. Vigilant Web Sitesine eri\u015fim ve bu Web Sitesinin kullan\u0131m\u0131, bu Kullan\u0131m Ko\u015fullar\u0131na ve y\u00fcr\u00fcrl\u00fckteki t\u00fcm yasalara, t\u00fcz\u00fcklere ve\/veya d\u00fczenlemelere tabidir. Bu nedenle, bu Web Sitesine eri\u015fiminiz veya bu Web Sitesini kullanman\u0131z, bu Kullan\u0131m Ko\u015fullar\u0131n\u0131 kabul etti\u011finizi ve en az on sekiz (18) ya\u015f\u0131nda veya daha b\u00fcy\u00fck oldu\u011funuzu beyan etti\u011finizi g\u00f6sterir.<\/p>\n

Web Sitemizin Kullan\u0131m\u0131<\/h2>\n

A\u015fa\u011f\u0131daki yasakl\u0131 faaliyetlerden herhangi birine kat\u0131lmamay\u0131 kabul edersiniz: (i) Web Sitesinin herhangi bir b\u00f6l\u00fcm\u00fcn\u00fc, otomatik veya otomatik olmayan \"kaz\u0131ma\" da dahil ancak bunlarla s\u0131n\u0131rl\u0131 olmamak \u00fczere herhangi bir ortamda kopyalamak, da\u011f\u0131tmak veya if\u015fa etmek; (ii) Vigilant sunucular\u0131na bir insan\u0131n makul olarak \u00fcretebilece\u011finden daha fazla istek mesaj\u0131 g\u00f6nderecek \u015fekilde Web Sitesine eri\u015fmek i\u00e7in \"robotlar\", \"\u00f6r\u00fcmcekler\", \"\u00e7evrimd\u0131\u015f\u0131 okuyucular\" vb. dahil ancak bunlarla s\u0131n\u0131rl\u0131 olmamak \u00fczere herhangi bir otomatik sistemi kullanmak. geleneksel bir \u00e7evrimi\u00e7i web taray\u0131c\u0131s\u0131n\u0131 kullanarak ayn\u0131 s\u00fcre i\u00e7inde; (iii) spam, zincirleme mektuplar veya di\u011fer istenmeyen e-postalar\u0131n iletilmesi; (iv) sistem b\u00fct\u00fcnl\u00fc\u011f\u00fcne veya g\u00fcvenli\u011fine m\u00fcdahale etmeye, tehlikeye atmaya veya Web Sitesini \u00e7al\u0131\u015ft\u0131ran sunuculara veya sunuculardan yap\u0131lan herhangi bir aktar\u0131m\u0131n \u015fifresini \u00e7\u00f6zmeye \u00e7al\u0131\u015fmak; (v) tamamen kendi takdirimize ba\u011fl\u0131 olarak altyap\u0131m\u0131za makul olmayan veya orant\u0131s\u0131z derecede b\u00fcy\u00fck bir y\u00fck getiren veya getirebilecek herhangi bir eylemde bulunmak; (vi) Web Sitesi arac\u0131l\u0131\u011f\u0131yla ge\u00e7ersiz veriler, vir\u00fcsler, solucanlar veya di\u011fer yaz\u0131l\u0131m arac\u0131lar\u0131n\u0131n y\u00fcklenmesi; (vii) Web Sitesinden ki\u015fisel olarak tan\u0131mlanabilir bilgilerin toplanmas\u0131 veya toplanmas\u0131; (viii) Web Sitesindeki herhangi bir i\u00e7eri\u011fe, Web Sitesi taraf\u0131ndan sa\u011flanan veya yetkilendirilenler d\u0131\u015f\u0131nda herhangi bir teknoloji veya ara\u00e7la eri\u015fim; veya (ix) herhangi bir i\u00e7eri\u011fin kullan\u0131m\u0131n\u0131 veya kopyalanmas\u0131n\u0131 engelleyen veya k\u0131s\u0131tlayan veya Web Sitesinin veya i\u00e7indeki i\u00e7eri\u011fin kullan\u0131m\u0131na s\u0131n\u0131rlama getiren \u00f6zellikler dahil ancak bunlarla s\u0131n\u0131rl\u0131 olmamak \u00fczere, Web Sitesine eri\u015fimi \u00f6nlemek veya k\u0131s\u0131tlamak i\u00e7in kullanabilece\u011fimiz \u00f6nlemlerin atlanmas\u0131.<\/p>\n

Vigilant, bu Kullan\u0131m Ko\u015fullar\u0131n\u0131n herhangi bir h\u00fckm\u00fcn\u00fc kendi karar\u0131m\u0131za g\u00f6re ihlal etmeniz de dahil olmak \u00fczere, herhangi bir nedenle veya hi\u00e7bir neden olmaks\u0131z\u0131n, herhangi bir bildirimde bulunmaks\u0131z\u0131n ve hi\u00e7bir sorumluluk \u00fcstlenmeksizin Web Sitesine eri\u015fiminizi kal\u0131c\u0131 veya ge\u00e7ici olarak sonland\u0131rabilir, ask\u0131ya alabilir veya ba\u015fka \u015fekilde buna izin vermeyi reddedebilir.<\/p>\n

Web Sitesinin t\u00fcm y\u00f6nleri tamamen Vigilant'\u0131n takdirine ba\u011fl\u0131 olarak de\u011fi\u015ftirilebilir veya ortadan kald\u0131r\u0131labilir. Vigilant, herhangi bir nedenle veya hi\u00e7bir neden olmaks\u0131z\u0131n, \u00f6nceden bildirimde bulunarak veya bulunmaks\u0131z\u0131n Web Sitesine eri\u015fimi veya Web Sitesinin i\u015fleyi\u015fini kesintiye u\u011fratma hakk\u0131n\u0131 sakl\u0131 tutar. Vigilant'\u0131n Web Sitesine eri\u015fimin veya Web Sitesinin i\u015fleyi\u015finin kesintiye u\u011framas\u0131, gecikmesi veya ger\u00e7ekle\u015ftirilememesi nedeniyle size kar\u015f\u0131 sorumlu olmayaca\u011f\u0131n\u0131 kabul edersiniz.<\/p>\n

Bu Web Sitesi, klinik ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131 da dahil olmak \u00fczere finansal hedeflere ve \u00fcr\u00fcn geli\u015ftirme \u00e7abalar\u0131na ili\u015fkin beklentiler de dahil olmak \u00fczere riskler ve belirsizlikler i\u00e7eren ileriye d\u00f6n\u00fck beyanlar i\u00e7erebilir. Vigilant'\u0131n ger\u00e7ek sonu\u00e7lar\u0131 ileriye d\u00f6n\u00fck beyanlarda yer alan sonu\u00e7lardan \u00f6nemli \u00f6l\u00e7\u00fcde farkl\u0131 olabilir.<\/p>\n

Bu Web Sitesinin kullan\u0131c\u0131lar\u0131, burada a\u00e7\u0131klanan geli\u015ftirilmekte olan \u00fcr\u00fcn\u00fcn\/\u00fcr\u00fcnlerin herhangi bir d\u00fczenleyici kurum veya otorite taraf\u0131ndan g\u00fcvenli veya etkili bulunmad\u0131\u011f\u0131n\u0131n ve klinik ara\u015ft\u0131rmalar d\u0131\u015f\u0131nda herhangi bir kullan\u0131m\u0131n onaylanmad\u0131\u011f\u0131n\u0131n bilincinde olmal\u0131d\u0131r. Bu Web Sitesinde sunulan bilgiler hi\u00e7bir \u015fekilde doktorunuz veya sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131n\u0131z taraf\u0131ndan sa\u011flanan t\u0131bbi tavsiyelerin yerine ge\u00e7ecek veya bunlar\u0131n yerine ge\u00e7ecek \u015fekilde yorumlanmamal\u0131 veya yorumlanmamal\u0131d\u0131r. TEDAV\u0130 SE\u00c7ENEKLER\u0130N\u0130Z\u0130 VE AKLINIZA GELEB\u0130LECEK T\u00dcM SORULARI DOKTORUNUZLA VEYA SA\u011eLIK KURUMUNUZLA G\u00d6R\u00dc\u015eMEN\u0130Z \u00d6NEML\u0130D\u0130R.<\/p>\n

Vigilant, bu Web Sitesinde sunulan bilgilere dayal\u0131 olarak herhangi bir eylem veya eylemsizlikten sorumlu tutulamaz ve bu Web Sitesinin t\u00fcm kullan\u0131c\u0131lar\u0131, bu Web Sitesine ve bu Web Sitesinde sunulan t\u00fcm i\u00e7eri\u011fe eri\u015fimin ve kullan\u0131m\u0131n kullan\u0131c\u0131ya ait oldu\u011funu kabul eder. kendi riski.<\/p>\n

M\u00fclkiyet Haklar\u0131m\u0131z<\/h2>\n

Vigilant, bu Kullan\u0131m Ko\u015fullar\u0131na uygun olarak bu Web Sitesine eri\u015fmeniz ve bu Web Sitesini kullanman\u0131z i\u00e7in size ki\u015fisel, m\u00fcnhas\u0131r olmayan, devredilemez bir lisans verir. Bu Web Sitesini kopyalayamaz veya bu Web Sitesini da\u011f\u0131tamaz, indiremez, de\u011fi\u015ftiremez, yeniden kullanamaz, yeniden yay\u0131nlayamaz veya ba\u015fka bir \u015fekilde istismar edemezsiniz. Ancak Vigilant, bu Web Sitesinde taraf\u0131m\u0131zdan yay\u0131nlanan belgeleri veya sayfalar\u0131, yaln\u0131zca ticari olmayan referans kullan\u0131m\u0131n\u0131z i\u00e7in kopyalaman\u0131za izin verir, ancak yapt\u0131\u011f\u0131n\u0131z herhangi bir kopyan\u0131n, burada yer alan t\u00fcm telif hakk\u0131 veya di\u011fer m\u00fclkiyet bildirimlerini ve t\u00fcm sorumluluk reddi beyanlar\u0131n\u0131 muhafaza etmesi ko\u015fuluyla. Bu Web Sitesinden ba\u015fka herhangi bir web sitesine ba\u011flant\u0131 verirseniz, bu sitelerde yer alan telif hakk\u0131 h\u00fck\u00fcmlerine uymal\u0131s\u0131n\u0131z.<\/p>\n

Yaz\u0131l\u0131m, resimler, metinler, grafikler, resimler, logolar, patentler, ticari markalar, hizmet markalar\u0131, telif haklar\u0131, foto\u011fraflar, ses ve videolar dahil ancak bunlarla s\u0131n\u0131rl\u0131 olmamak \u00fczere Web Sitesi ve burada yer alan veya aktar\u0131lan t\u00fcm materyaller (\"\u0130\u00e7erik\") ve bununla ilgili t\u00fcm Fikri M\u00fclkiyet Haklar\u0131 (a\u015fa\u011f\u0131da tan\u0131mland\u0131\u011f\u0131 gibi), telif hakk\u0131yla korunmaktad\u0131r ve Vigilant ile lisans verenlerinin m\u00fcnhas\u0131r m\u00fclkiyetindedir. Bu Kullan\u0131m Ko\u015fullar\u0131n\u0131n ama\u00e7lar\u0131 do\u011frultusunda, \"Fikri M\u00fclkiyet Haklar\u0131\" t\u00fcm patent haklar\u0131, telif hakk\u0131 haklar\u0131, maske \u00e7al\u0131\u015fma haklar\u0131, manevi haklar, tan\u0131t\u0131m haklar\u0131, ticari marka, ticari takdim \u015fekli ve hizmet markas\u0131 haklar\u0131, \u015ferefiye, ticari s\u0131r haklar\u0131 ve di\u011fer fikri m\u00fclkiyet haklar\u0131 anlam\u0131na gelir. \u015eu anda var olabilecek veya bundan sonra ortaya \u00e7\u0131kabilecek m\u00fclkiyet haklar\u0131 ve bunlara y\u00f6nelik t\u00fcm ba\u015fvurular ve tesciller, yenilemeler ve uzatmalar, herhangi bir eyalet, \u00fclke, b\u00f6lge veya di\u011fer yarg\u0131 yetkisinin yasalar\u0131 kapsam\u0131ndad\u0131r. Vigilant ad\u0131 ve logosu ve Web Sitesinde g\u00f6r\u00fcnen t\u00fcm \u00fcr\u00fcn adlar\u0131, b\u00fcy\u00fck harflerle veya ticari marka sembol\u00fcyle g\u00f6r\u00fcn\u00fcp g\u00f6r\u00fcnmedi\u011fine bak\u0131lmaks\u0131z\u0131n Vigilant'\u0131n, onun lisans sahiplerinin, lisans verenlerinin veya di\u011fer \u00fc\u00e7\u00fcnc\u00fc taraflar\u0131n ticari markalar\u0131d\u0131r. Burada a\u00e7\u0131k\u00e7a belirtilmedi\u011fi s\u00fcrece, bu Kullan\u0131m Ko\u015fullar\u0131ndaki hi\u00e7bir \u015fey, \u0130\u00e7erikteki herhangi bir Fikri M\u00fclkiyet Hakk\u0131 kapsam\u0131nda veya kapsam\u0131nda bir lisans olu\u015fturmaz ve satmamay\u0131, lisanslamamay\u0131, kiralamamay\u0131, de\u011fi\u015ftirmemeyi, da\u011f\u0131tmamay\u0131, kopyalamamay\u0131, \u00e7o\u011faltmamay\u0131, iletmemeyi kabul edersiniz. Web Sitesinde eri\u015filebilen herhangi bir materyali veya \u0130\u00e7eri\u011fi kamuya a\u00e7\u0131k olarak g\u00f6r\u00fcnt\u00fclemek, kamuya a\u00e7\u0131k olarak ger\u00e7ekle\u015ftirmek, yay\u0131nlamak, uyarlamak, d\u00fczenlemek veya bunlardan t\u00fcrev \u00e7al\u0131\u015fmalar olu\u015fturmak veya bu t\u00fcr materyalleri veya \u0130\u00e7eri\u011fi, bu Kullan\u0131m Ko\u015fullar\u0131nda a\u00e7\u0131k\u00e7a izin verilmeyen herhangi bir ama\u00e7 i\u00e7in kullanmak.<\/p>\n

Bu Web Sitesi veya internet elektronik postas\u0131 arac\u0131l\u0131\u011f\u0131yla Vigilant'a iletti\u011finiz her t\u00fcrl\u00fc ileti\u015fim, taraf\u0131n\u0131zca gizli olmayan bir \u015fekilde iletilir. Vigilant, bu t\u00fcr ileti\u015fim veya materyali \u00e7o\u011faltma, yay\u0131nlama, yay\u0131nlama ve ilan etme dahil olmak \u00fczere herhangi bir ama\u00e7la kullanmayaca\u011f\u0131na dair a\u00e7\u0131k veya z\u0131mni hi\u00e7bir s\u00f6z vermez. A\u00e7\u0131klaman\u0131z\u0131n kar\u015f\u0131l\u0131ks\u0131z, talep edilmeden ve k\u0131s\u0131tlama olmaks\u0131z\u0131n yap\u0131ld\u0131\u011f\u0131n\u0131 ve Vigilant'\u0131 herhangi bir vekalet veya ba\u015fka bir y\u00fck\u00fcml\u00fcl\u00fck alt\u0131na sokmayaca\u011f\u0131n\u0131 ve size herhangi bir ek tazminat \u00f6demeden bu ileti\u015fimi kullanmakta \u00f6zg\u00fcr oldu\u011fumuzu kabul edersiniz. Ayr\u0131ca, ileti\u015fiminizi kabul ederek, Vigilant'\u0131n daha \u00f6nce Vigilant taraf\u0131ndan bilinen, \u00e7al\u0131\u015fanlar\u0131 taraf\u0131ndan geli\u015ftirilen veya sizin d\u0131\u015f\u0131n\u0131zdaki kaynaklardan elde edilen benzer veya ilgili fikirleri kullanma hakk\u0131ndan feragat etmedi\u011fini kabul edersiniz.<\/p>\n

Herhangi bir \u0130\u00e7eri\u011fin veya Fikri M\u00fclkiyet Haklar\u0131n\u0131n, burada izin verilen kapsam d\u0131\u015f\u0131nda kullan\u0131lmas\u0131 veya k\u00f6t\u00fcye kullan\u0131lmas\u0131 a\u00e7\u0131k\u00e7a yasakt\u0131r ve telif hakk\u0131 yasas\u0131n\u0131, ticari marka yasas\u0131n\u0131, ileti\u015fim d\u00fczenlemelerini ve t\u00fcz\u00fcklerini ve di\u011fer yasa, y\u00f6netmelik ve\/veya t\u00fcz\u00fckleri ihlal edebilir.<\/p>\n

G\u00fcvenlik<\/h2>\n

Vigilant, bilgi ve ileti\u015fimleri kazara kaybolmaya ve yetkisiz eri\u015fime, kullan\u0131ma, de\u011fi\u015ftirilmeye veya if\u015fa edilmeye kar\u015f\u0131 korumak i\u00e7in tasarlanm\u0131\u015f ticari a\u00e7\u0131dan makul teknik ve organizasyonel \u00f6nlemleri uygulamaya koymu\u015ftur. Ancak, yetkisiz \u00fc\u00e7\u00fcnc\u00fc taraflar\u0131n bu taraflar\u0131n \u00f6nlemlerini hi\u00e7bir zaman bo\u015fa \u00e7\u0131karamayaca\u011f\u0131n\u0131 veya bilgileri veya ileti\u015fimleri uygunsuz ama\u00e7larla kullanamayaca\u011f\u0131n\u0131 garanti edemeyiz. Herhangi bir bilgi veya ileti\u015fimi riski size ait olmak \u00fczere sa\u011flad\u0131\u011f\u0131n\u0131z\u0131 kabul edersiniz.<\/p>\n

\u00dc\u00e7\u00fcnc\u00fc Taraf Ba\u011flant\u0131lar\u0131<\/h2>\n

Bu Web Sitesindeki belirli ba\u011flant\u0131lar, Vigilant'\u0131n \u00fczerinde hi\u00e7bir kontrol\u00fcn\u00fcn bulunmad\u0131\u011f\u0131, \u00fc\u00e7\u00fcnc\u00fc taraflarca tutulan kaynaklara y\u00f6nlendirmektedir. Bu nedenle, Vigilant ba\u015fka herhangi bir web sitesinde sunulan herhangi bir \u00fcr\u00fcn veya hizmetin i\u00e7eri\u011fini veya kullan\u0131m\u0131n\u0131 rutin olarak taramaz, onaylamaz veya incelemez ve sorumlu de\u011fildir ve Vigilant, ger\u00e7e\u011fi kabul etmez, onaylamaz, g\u00f6r\u00fc\u015f bildirmez veya herhangi bir beyanda bulunmaz. Bu kaynaklarda yer alan bilgilerin do\u011frulu\u011fu, yasall\u0131\u011f\u0131 veya di\u011fer y\u00f6nleri.<\/p>\n

Haberler ve Bas\u0131n B\u00fcltenleri<\/h2>\n

Bu Web Sitesi, i\u00e7eri\u011fi yaln\u0131zca s\u00f6z konusu bilgi, haber, bas\u0131n b\u00fclteni veya g\u00f6nderi tarihi itibariyle do\u011fru veya g\u00fcncel olan bilgiler, haberler ve\/veya bas\u0131n b\u00fcltenleri i\u00e7erebilir. Vigilant, bas\u0131n b\u00fcltenleri kamuya a\u00e7\u0131kland\u0131ktan sonra g\u00fcncellemez.<\/p>\n

garanti yok<\/h2>\n

WEB S\u0130TES\u0130 \u201cOLDU\u011eU G\u0130B\u0130\u201d VE \u201cMEVCUT OLDU\u011eU \u015eEK\u0130LDE\u201d SUNULMAKTADIR. WEB S\u0130TES\u0130N\u0130 KULLANMANIN R\u0130SKLER\u0130 S\u0130ZE A\u0130TT\u0130R. GE\u00c7ERL\u0130 YASALARIN \u0130Z\u0130N VERD\u0130\u011e\u0130 AZAM\u0130 \u00d6L\u00c7\u00dcDE, WEB S\u0130TES\u0130, T\u0130CAR\u0130 ELVER\u0130\u015eL\u0130L\u0130K, BEL\u0130RL\u0130 B\u0130R AMACA UYGUNLUK VEYA \u0130HLAL OLMAMASI DAH\u0130L ANCAK BUNLARLA SINIRLI OLMAMAK \u00dcZERE A\u00c7IK VEYA ZIMN\u0130 HERHANG\u0130 B\u0130R GARANT\u0130 OLMAKSIZIN SA\u011eLANIR. S\u0130Z\u0130N TARAFINIZDAN VIGILANT'TAN VEYA WEB S\u0130TES\u0130NDEN ALINAN S\u00d6ZL\u00dc VEYA YAZILI H\u0130\u00c7B\u0130R TAVS\u0130YE VEYA B\u0130LG\u0130, BURADA A\u00c7IK\u00c7A BEL\u0130RT\u0130LMEYEN HERHANG\u0130 B\u0130R GARANT\u0130 OLU\u015eTURMAZ. YUKARIDA BEL\u0130RT\u0130LENLER\u0130 SINIRLAMAKSIZIN, NE VIGILANT NE DE BA\u011eLI KURULU\u015eLARI, BA\u011eLI KURULU\u015eLARI, L\u0130SANS VERENLER\u0130, L\u0130SANS SAH\u0130PLER\u0130, HALEFLER\u0130 VEYA DEVRALANANLARI \u0130\u00c7ER\u0130\u011e\u0130N DO\u011eRU, TAM, G\u00dcNCEL, YARARLI, G\u00dcVEN\u0130L\u0130R VEYA DO\u011eRU OLDU\u011eUNU GARANT\u0130 ETMEMEKTED\u0130R; WEB S\u0130TES\u0130N\u0130N \u0130HT\u0130YA\u00c7LARINIZI KAR\u015eILAYACA\u011eINI; WEB S\u0130TES\u0130N\u0130N BEL\u0130RL\u0130 B\u0130R ZAMAN VE YERDE KES\u0130NT\u0130S\u0130Z, HATASIZ VEYA G\u00dcVENL\u0130 OLACA\u011eINI; HER T\u00dcRL\u00dc KUSUR VEYA HATALARIN D\u00dcZELT\u0130LECE\u011e\u0130NE; VEYA WEB S\u0130TES\u0130N\u0130N V\u0130R\u00dcS VEYA D\u0130\u011eER ZARARLI B\u0130LE\u015eENLER \u0130\u00c7ERMED\u0130\u011e\u0130N\u0130. WEB S\u0130TES\u0130N\u0130N KULLANIMI YOLUYLA \u0130ND\u0130R\u0130LEN VEYA BA\u015eKA B\u0130R \u015eEK\u0130LDE ELDE ED\u0130LEN HERHANG\u0130 B\u0130R \u0130\u00c7ER\u0130K \u0130ND\u0130R\u0130LMES\u0130N\u0130N R\u0130SKLER\u0130 S\u0130ZE A\u0130TT\u0130R VE BU \u0130ND\u0130RMEDEN KAYNAKLANAN B\u0130LG\u0130SAYAR S\u0130STEM\u0130N\u0130ZDEK\u0130 HERHANG\u0130 B\u0130R HASARDAN VEYA VER\u0130 KAYBI VEYA D\u0130\u011eER KULLANIM KAYIPLARINDAN YALNIZCA S\u0130Z SORUMLU OLACAKSINIZ.<\/p>\n

VIGILANT, WEB S\u0130TES\u0130 VEYA HERHANG\u0130 B\u0130R K\u00d6PR\u00dc BA\u011eLANTILI WEB S\u0130TES\u0130NDE VEYA H\u0130ZMET \u00dcZER\u0130NDEN \u00dc\u00c7\u00dcNC\u00dc B\u0130R \u015eAHIS TARAFINDAN REKLAM ED\u0130LEN VEYA SUNULAN VEYA HERHANG\u0130 B\u0130R BANNER VEYA BA\u015eKA REKLAMDA \u00d6NE \u00c7IKAN HERHANG\u0130 B\u0130R \u00dcR\u00dcN VEYA H\u0130ZMET \u0130\u00c7\u0130N GARANT\u0130 VERMEZ, ONAYLAMAZ, GARANT\u0130 VEYA SORUMLULUK KABUL ETMEZ VE VIGILANT TARAF OLMAYACAKTIR S\u0130Z VE \u00dc\u00c7\u00dcNC\u00dc TARAF \u00dcR\u00dcN VEYA H\u0130ZMET SA\u011eLAYICILARI ARASINDAK\u0130 HERHANG\u0130 B\u0130R \u0130\u015eLEM\u0130 \u0130ZLEMEK VEYA HERHANG\u0130 B\u0130R \u015eEK\u0130LDE \u0130ZLEMEK.<\/p>\n

Sorumlulu\u011fun S\u0131n\u0131rland\u0131r\u0131lmas\u0131<\/h2>\n

GE\u00c7ERL\u0130 YASALARIN \u0130Z\u0130N VERD\u0130\u011e\u0130 AZAM\u0130 \u00d6L\u00c7\u00dcDE, VIGILANT, BA\u011eLI ORTAKLIKLARI, BA\u011eLI \u015e\u0130RKETLER\u0130, ACENTELER\u0130, Y\u00d6NET\u0130C\u0130LER\u0130, G\u00d6REVL\u0130LER\u0130, \u00c7ALI\u015eANLARI, TEDAR\u0130K\u00c7\u0130LER\u0130 VEYA Y\u00dcKLEN\u0130C\u0130LER\u0130 VEYA L\u0130SANS VERENLER\u0130 VEYA L\u0130SANS SAH\u0130PLER\u0130 H\u0130\u00c7B\u0130R DURUMDA, HERHANG\u0130 B\u0130R DO\u011eRUDAN, DOLAYLI, CEZA\u0130, ARIZ\u0130, WEB S\u0130TES\u0130N\u0130N KULLANIMI VEYA KULLANILAMAMASI VEYA \u0130\u00c7ER\u0130KTEK\u0130 HERHANG\u0130 B\u0130R HATA VEYA EKS\u0130KL\u0130KTEN KAYNAKLANAN, K\u00c2R KAYBI, \u0130Y\u0130 N\u0130YET, KULLANIM, VER\u0130 VEYA D\u0130\u011eER MADD\u0130 OLMAYAN KAYIPLAR DAH\u0130L ANCAK BUNLARLA SINIRLI OLMAMAK \u00dcZERE \u00d6ZEL, SONU\u00c7 OLARAK ORTAYA \u00c7IKAN ZARARLAR VEYA \u00d6RNEK OLAN ZARARLAR. VIGILANT H\u0130\u00c7B\u0130R KO\u015eUL ALTINDA, WEB S\u0130TES\u0130N\u0130N VEYA \u0130\u00c7ER\u0130\u011e\u0130NDE \u0130\u00c7EREN B\u0130LG\u0130LER\u0130N HACKLENME, DE\u011e\u0130\u015eT\u0130RME VEYA D\u0130\u011eER YETK\u0130S\u0130Z ER\u0130\u015e\u0130M VEYA KULLANIMINDAN KAYNAKLANAN HERHANG\u0130 B\u0130R ZARAR, KAYIP VEYA YARALANMADAN SORUMLU OLMAYACAKTIR.<\/p>\n

GE\u00c7ERL\u0130 YASALARIN \u0130Z\u0130N VERD\u0130\u011e\u0130 AZAM\u0130 \u00d6L\u00c7\u00dcDE, VIGILANT HERHANG\u0130 B\u0130R (I) \u0130\u00c7ER\u0130Kteki HATALAR, HATALAR VEYA YANLI\u015eLIKLARDAN; (II) WEB S\u0130TES\u0130NE ER\u0130\u015e\u0130M\u0130N\u0130ZDEN VEYA WEB S\u0130TES\u0130N\u0130 KULLANMANIZDAN KAYNAKLANAN, HERHANG\u0130 B\u0130R N\u0130TEL\u0130\u011e\u0130NDEK\u0130 K\u0130\u015e\u0130SEL VEYA BEDENSEL YARALANMA VEYA MAL HASARI; (III) G\u00dcVENL\u0130 SUNUCULARIMIZA VE\/VEYA BURADA SAKLANAN HERHANG\u0130 B\u0130R VE T\u00dcM K\u0130\u015e\u0130SEL B\u0130LG\u0130LERE YETK\u0130S\u0130Z ER\u0130\u015e\u0130M VEYA ONLARIN KULLANIMI; (IV) WEB S\u0130TES\u0130NE VEYA WEB S\u0130TES\u0130NDEN \u0130LET\u0130M\u0130N HERHANG\u0130 B\u0130R KES\u0130NT\u0130S\u0130 VEYA DURDURULMASI; (V) HERHANG\u0130 B\u0130R \u00dc\u00c7\u00dcNC\u00dc TARAFCA WEB S\u0130TES\u0130NE VEYA \u00dcZER\u0130NDEN \u0130LET\u0130LEB\u0130LECEK HER T\u00dcRL\u00dc HATA, V\u0130R\u00dcS, truva at\u0131 VEYA BENZERLER\u0130; (VI) HERHANG\u0130 B\u0130R \u0130\u00c7ER\u0130KTEK\u0130 HERHANG\u0130 B\u0130R HATA VEYA EKS\u0130KL\u0130K VEYA WEB S\u0130TES\u0130NDEN VEYA WEB S\u0130TES\u0130NDEN YAYINLANAN, E-POSTA OLARAK G\u00d6NDER\u0130LEN, AKTARILAN VEYA BA\u015eKA B\u0130R \u015eEK\u0130LDE SUNULAN HERHANG\u0130 B\u0130R \u0130\u00c7ER\u0130\u011e\u0130N KULLANIMI SONUCUNDA ORTAYA \u00c7IKAN HERHANG\u0130 B\u0130R KAYIP VEYA ZARAR; VE\/VEYA (VII) HERHANG\u0130 B\u0130R \u00dc\u00c7\u00dcNC\u00dc TARAFIN \u0130FT\u0130RACI, SALDIRGAN VEYA YASA DI\u015eI DAVRANI\u015eI. VIGILANT, BA\u011eLI ORTAKLIKLARI, BA\u011eLI KURULU\u015eLARI, ACENTELER\u0130, Y\u00d6NET\u0130C\u0130LER\u0130, MEMURLARI, \u00c7ALI\u015eANLARI, TEDAR\u0130K\u00c7\u0130LER\u0130, Y\u00dcKLEN\u0130C\u0130LER\u0130, L\u0130SANS SAH\u0130PLER\u0130 VEYA L\u0130SANS VERENLER\u0130 HERHANG\u0130 B\u0130R \u0130DD\u0130A, DAVA, DAVA, \u0130\u015eLEM, Y\u00dcK\u00dcML\u00dcL\u00dcK, Y\u00dcK\u00dcML\u00dcL\u00dcK, ZARAR, KAYIP, MAL\u0130YET VEYA BU KULLANIM KO\u015eULLARI, WEB S\u0130TES\u0130 VEYA \u0130\u00c7ER\u0130K \u0130LE BA\u011eLANTILI OLARAK ELL\u0130 DOLARI (50,00 $) A\u015eAN M\u0130KTARDA MASRAFLAR.<\/p>\n

BU KULLANIM KO\u015eULLARINDA BEL\u0130RT\u0130LEN SORUMLULUK SINIRLAMASI, \u0130DD\u0130A ED\u0130LEN SORUMLULUK S\u00d6ZLE\u015eME, HAKSIZ F\u0130\u0130L, \u0130HMAL, GARANT\u0130 \u0130HLAL\u0130NE, KUSURSUZ SORUMLULU\u011eA VEYA BA\u015eKA HERHANG\u0130 B\u0130R ESASA DAYANIR OLSUN, VIGILANT'IN OLASILI\u011eI B\u0130LMES\u0130 VEYA BU OLASILIK HAKKINDA B\u0130LG\u0130LEND\u0130R\u0130LM\u0130\u015e OLMASI GEREK\u0130RSE B\u0130LE GE\u00c7ERL\u0130D\u0130R BU T\u00dcR ZARARLARDAN. SORUMLULUK SINIRLAMASI, GE\u00c7ERL\u0130 YARGI ALANINDA YASALARIN \u0130Z\u0130N VERD\u0130\u011e\u0130 EN GEN\u0130\u015e \u00d6L\u00c7\u00dcDE GE\u00c7ERL\u0130 OLACAKTIR.<\/p>\n

Web Sitesi Amerika Birle\u015fik Devletleri'ndeki tesislerden kontrol edilmekte ve i\u015fletilmektedir. Vigilant, Web Sitesinin ba\u015fka yerlerde kullan\u0131ma uygun veya mevcut oldu\u011funa dair hi\u00e7bir beyanda bulunmaz. Web Sitesine di\u011fer yarg\u0131 b\u00f6lgelerinden eri\u015fenler veya Web Sitesini kullananlar bunu kendi istekleriyle yaparlar ve ihracat ve ithalat d\u00fczenlemeleri dahil ancak bunlarla s\u0131n\u0131rl\u0131 olmamak \u00fczere ge\u00e7erli t\u00fcm Amerika Birle\u015fik Devletleri yasalar\u0131na ve yerel yasa ve d\u00fczenlemelere uymaktan tamamen sorumludurlar. Amerika Birle\u015fik Devletleri taraf\u0131ndan ambargo uygulanan bir \u00fclkede ikamet ediyorsan\u0131z veya Amerika Birle\u015fik Devletleri h\u00fck\u00fcmeti taraf\u0131ndan engellenen veya reddedilen yabanc\u0131 bir ki\u015fi veya kurulu\u015fsan\u0131z Web Sitesini kullanamazs\u0131n\u0131z. Aksi a\u00e7\u0131k\u00e7a belirtilmedi\u011fi s\u00fcrece, Web Sitesinde bulunan t\u00fcm materyaller yaln\u0131zca Amerika Birle\u015fik Devletleri'nde bulunan bireylere, \u015firketlere veya di\u011fer kurulu\u015flara y\u00f6neliktir.<\/p>\n

Mahremiyet<\/h2>\n

Ki\u015fisel bilgileriniz, burada yer alan ve buraya referans olarak dahil edilen Gizlilik Politikam\u0131za uygun olarak ele al\u0131nacakt\u0131r. Bu Web Sitesini kullan\u0131rsan\u0131z, Gizlilik Politikas\u0131n\u0131n h\u00fck\u00fcm ve ko\u015fullar\u0131n\u0131 da kabul etmi\u015f olursunuz. Bilgilerinizin Gizlilik Politikas\u0131nda a\u00e7\u0131klanan yollardan herhangi birinde kullan\u0131lmas\u0131n\u0131 kabul etmiyorsan\u0131z, herhangi bir bilgi vermemelisiniz.<\/p>\n

Genel<\/h2>\n
    \n
  1. Ge\u00e7erli Hukuk Bu Kullan\u0131m Ko\u015fullar\u0131, Florida Eyaleti'nin veya ba\u015fka herhangi bir yarg\u0131 b\u00f6lgesinin kanunlar ihtilaf\u0131 ilkelerine bak\u0131lmaks\u0131z\u0131n, Florida Eyaleti'nin i\u00e7 maddi kanunlar\u0131na g\u00f6re y\u00f6netilecek, kontrol edilecek ve yorumlanacakt\u0131r. Bu Web Sitesini kullanarak, Vigilant'\u0131n bu Kullan\u0131m \u015eartlar\u0131ndan kaynaklanan veya bunlarla ilgili olarak size kar\u015f\u0131 a\u00e7t\u0131\u011f\u0131 herhangi bir dava i\u00e7in Vigilant'\u0131n ana i\u015f yerinin bulundu\u011fu il\u00e7edeki eyalet ve federal mahkemelerin ki\u015fisel yarg\u0131 yetkisine ve mahkeme yerine a\u00e7\u0131k\u00e7a izin vermi\u015f olursunuz. Kullanmak.<\/li>\n
  2. B\u00f6l\u00fcnebilirlik Bu Kullan\u0131m Ko\u015fullar\u0131n\u0131n herhangi bir h\u00fckm\u00fc yetkili bir mahkeme taraf\u0131ndan ge\u00e7ersiz say\u0131l\u0131rsa, s\u00f6z konusu h\u00fckm\u00fcn ge\u00e7ersizli\u011fi bu Kullan\u0131m Ko\u015fullar\u0131n\u0131n tam olarak y\u00fcr\u00fcrl\u00fckte kalacak olan geri kalan h\u00fck\u00fcmlerinin ge\u00e7erlili\u011fini etkilemeyecektir.<\/li>\n
  3. Feragat Yok Bu Kullan\u0131m Ko\u015fullar\u0131n\u0131n herhangi bir \u015fart\u0131ndan feragat edilmesi, s\u00f6z konusu \u015fart veya ba\u015fka bir \u015farttan daha fazla veya devam eden bir feragat olarak kabul edilmeyecektir ve Vigilant'\u0131n bu Kullan\u0131m \u015eartlar\u0131 kapsam\u0131nda herhangi bir hak veya h\u00fck\u00fcm ileri s\u00fcrmemesi, bu t\u00fcr bir haktan feragat anlam\u0131na gelmeyecektir. veya sa\u011flanmas\u0131.<\/li>\n<\/ol>\n

    L\u00fctfen bizimle ileti\u015fime ge\u00e7in\u00a0<\/span>info@VigilantBiosciences.com<\/a>\u00a0<\/span>L\u00fctfen bizimle ileti\u015fime ge\u00e7in<\/p>\n

    Bu Kullan\u0131m Ko\u015fullar\u0131 en son 15 Nisan 2020'de g\u00fcncellenmi\u015ftir.<\/p>\n

    [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

    Kullan\u0131m Ko\u015fullar\u0131 Vigilant Biosciences\u00ae, Inc.'in ("Vigilant", "biz" veya "bize") web sitesi olan https:\/\/vigilantbiosciences.com'a ho\u015f geldiniz. Vigilant Web Sitesi (\u201cWeb Sitesi\u201d) Vigilant ve \u00fcr\u00fcnleri hakk\u0131nda genel bilgi sa\u011flamak \u00fczere tasarlanm\u0131\u015ft\u0131r ve Vigilant bu Web Sitesini \u0130nternet toplulu\u011funa bir hizmet olarak s\u00fcrd\u00fcrmektedir. Bu Web Sitesinde yer alan bilgiler yat\u0131r\u0131m sa\u011flama veya [\u2026]<\/p>","protected":false},"author":1,"featured_media":248,"parent":0,"menu_order":30,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"class_list":["post-502","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nNews - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"News and updates about oral cancer screening, new technologies in oral cancer care, and other oral cancer developments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/tr\/kullanim-sartlari\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"News and updates about oral cancer screening, new technologies in oral cancer care, and other oral cancer developments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/tr\/kullanim-sartlari\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/Solutions-Page-header-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1923\" \/>\n\t<meta property=\"og:image:height\" content=\"397\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/terms-of-use\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/terms-of-use\/\",\"name\":\"News - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-09-21T20:52:20+00:00\",\"dateModified\":\"2023-09-21T20:52:20+00:00\",\"description\":\"News and updates about oral cancer screening, new technologies in oral cancer care, and other oral cancer developments.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/terms-of-use\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/terms-of-use\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/terms-of-use\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Terms of Use\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News - Vigilant Biosciences\u00ae","description":"News and updates about oral cancer screening, new technologies in oral cancer care, and other oral cancer developments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/tr\/kullanim-sartlari\/","og_locale":"tr_TR","og_type":"article","og_title":"News - Vigilant Biosciences\u00ae","og_description":"News and updates about oral cancer screening, new technologies in oral cancer care, and other oral cancer developments.","og_url":"https:\/\/vigilantbiosciences.com\/tr\/kullanim-sartlari\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","og_image":[{"width":1923,"height":397,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/Solutions-Page-header-image.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tahmini okuma s\u00fcresi":"7 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/terms-of-use\/","url":"https:\/\/vigilantbiosciences.com\/terms-of-use\/","name":"News - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-09-21T20:52:20+00:00","dateModified":"2023-09-21T20:52:20+00:00","description":"News and updates about oral cancer screening, new technologies in oral cancer care, and other oral cancer developments.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/terms-of-use\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/terms-of-use\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/terms-of-use\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"Terms of Use"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/pages\/502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/comments?post=502"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/pages\/502\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/media\/248"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/tr\/wp-json\/wp\/v2\/media?parent=502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}